|
⚲
|
| Keyboard |
| Jayne David RW
✚
|
|
|---|---|
| CIK # | 0001838242 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001838242] | |
| 4 | [0001838242] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Aurinia Pharmaceuticals Inc | |
| Jayne David RW |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Aurinia Pharmaceuticals Inc AUPH
Common Shares
|
2024-11-21 | Grant | 12,135 | $0.00 | |
|
Aurinia Pharmaceuticals Inc AUPH
Director Stock Option (right to buy) · derivative
|
2024-11-21 | Grant | 18,641 | $0.00 | |
|
Aurinia Pharmaceuticals Inc AUPH
Common Stock
|
2024-05-21 | Sell | 4,946 | $5.74 | 28,390 |
|
Aurinia Pharmaceuticals Inc AUPH
Common Stock
|
2023-05-23 | Sell | 8,733 | $11.26 | 98,334 |
|
Aurinia Pharmaceuticals Inc AUPH
Common Stock
|
2023-05-19 | Grant | 9,310 | $0.00 | |
|
Aurinia Pharmaceuticals Inc AUPH
Stock Option (right to buy) · derivative
|
2023-05-19 | Grant | 15,234 | $0.00 | |
|
Aurinia Pharmaceuticals Inc AUPH
Common Stock
|
2023-05-18 | Option exercise | 8,733 | ||
|
Aurinia Pharmaceuticals Inc AUPH
Restricted Stock Units · derivative
|
2023-05-18 | Option exercise | 8,733 | $0.00 | |
|
Aurinia Pharmaceuticals Inc AUPH
Restricted Stock Unit · derivative
|
2022-05-18 | Grant | 8,733 | $0.00 | |
|
Aurinia Pharmaceuticals Inc AUPH
Stock Option (right to buy) · derivative
|
2022-05-18 | Grant | 14,612 | $0.00 | |
|
Aurinia Pharmaceuticals Inc AUPH
Stock Option (right to buy) · derivative
|
2021-06-14 | Grant | 31,347 | $0.00 |